$20 copay for Zytiga (Abiraterone)

New Topic Post Reply Printable Version
[ << Previous Thread | Next Thread >> ]

RISHMA
New Member


Date Joined Jun 2011
Total Posts : 1
   Posted 6/22/2011 9:49 PM (GMT -6)   
The maker of Zytiga is offering a program where they pay all but $20 of your insurance copay.  There is no financial need criteria.  Here is how to enroll.
  1. go to Zytiga.com and click on "Patients & Caregivers / Coverage Questions"
  2. on the page that opens, click on the Zytiga icon
  3. on the page that opens, click on "ZytigaOne Instant Savings Program" on the right side of the page
  4. from this point, it is pretty easy to follow. 

I received my perscription today and the cost really was $20.  No gimics - no surprises.


Tony Crispino
Veteran Member


Date Joined Dec 2006
Total Posts : 7663
   Posted 6/23/2011 1:19 AM (GMT -6)   
RISHMA,
We usually have issue with first time posters posting links. However in your case I see a need to let this one pass. This is a legit offer from Centocor Ortho Biotech ~ the makers of Zytiga (abiraterone acetate).

It should be noted that many of the pharmaceuticals offer programs for the financially destitute. It is always a good idea to contact them and ask. Many times they can also provide the providor to administer the drugs.

Just a thought. Anyone of our advanced case members in need of considering Zytiga, but are unable to pay for it, should contact this website and at least enquire.

Tony
Advanced Prostate Cancer at age 44 (I am 48 now)
pT3b,N0,Mx (original PSA was 19.8) EPE, PM, SVI. Gleason 4+3=7

Treatments:
Da Vinci Surgery ~ 2/16/2007
Adjuvant Radiation Therapy ~ IMRT Completed 8/07
Adjuvant Hormone Therapy ~ 28 months on Casodex and Lupron.
Undetectable PSA.

Blog: www.caringbridge.org/visit/tonycrispino

Viperguy
Regular Member


Date Joined Nov 2010
Total Posts : 243
   Posted 6/23/2011 4:20 AM (GMT -6)   
Hi Rishma,

Who knows, you may have put someone on track to extend or save a life.

Thanks for the contribution
57 years old
2009 PSA 2.2
2010 PSA 3.2
Biopsy 24 cores 3 positive
Gleason 3 plus 3
Robotic Surgery March 3, 2011 @ 6 am
Believe it or not it didn't hurt much (1 pain pill)
Cath removal 3/17/11
Still Leaking 04/21/11 but getting better
05/26/11 leakage is much improved one small pad daily
ED an issue but helped just a bit with a pill
Recovery is slow but sure
First post op PSA 0.04

Steve n Dallas
Veteran Member


Date Joined Mar 2008
Total Posts : 4011
   Posted 6/23/2011 4:45 AM (GMT -6)   
You don't have to be financially destitute...
 
Lunesta for example will cover co-pays up to $50.00 a total of 12 times. So checking web sites of the pharm companies is now on my list of things to do.

zufus
Veteran Member


Date Joined Dec 2008
Total Posts : 3136
   Posted 6/23/2011 6:07 AM (GMT -6)   
Zytiga support: 1=855-ZYTIGA or (998-4421) M-F 8 am. to 8 pm (info line),  Centocor Ortho Biotech 1-800-457-6399  (Mfg. by Patheon, Inc.-Toronto, Canada), maybe buy stock in it?
(in the program there are yearly limits, so read the whole thing of course)

The promo at AUA 2011: http://preview.tinyurl.com/3tw5qat       

Post Edited (zufus) : 6/23/2011 5:13:14 AM (GMT-6)


zufus
Veteran Member


Date Joined Dec 2008
Total Posts : 3136
   Posted 6/24/2011 11:31 AM (GMT -6)   
Bumped- cause of new info link concerning 'Flare issues' found in about 1/3 of patients using this, via scans this was found:
The results of the study showed the following:

•22/33 patients (67 percent) had a PSA decline of ≥ 50 percent at week 12.
•26/33 patients (76 percent) had a PSA decline of ≥ 50 percent overall.
•Undetectable PSA levels (≤ 0.1 ng/ml) were documented in two patients.
•Average (median) time on therapy was 63 weeks.
•Average (median) time to PSA progression was 16.3 months.
•23/33 patients (70 percent) were evaluable for bone scan flare.
◦12/23 evaluable patients (52 percent) showed disease progression on bone scan, as indicated in radiologists’ reports.
◦11/12 patients showing signs of progression subsequently showed improvement or stability.
•As defined above, bone scan flare was observed in 11/23 evaluable patients (48 percent) or 11/33 enrolled patients (patients).
•Adverse events to abiraterone therapy were typically grade 1/2 and were consistent with adverse events in prior published reports

http://prostatecancerinfolink.net/    (the source of this claim and quoted studieds above)
Not against choices for patients, do advise people to know all they can and look at everything, without being rushed into any decisions on anything.

Post Edited (zufus) : 6/24/2011 10:34:28 AM (GMT-6)

New Topic Post Reply Printable Version
Forum Information
Currently it is Sunday, September 21, 2014 1:00 AM (GMT -6)
There are a total of 2,222,895 posts in 247,356 threads.
View Active Threads


Who's Online
This forum has 156552 registered members. Please welcome our newest member, DianeTS.
237 Guest(s), 7 Registered Member(s) are currently online.  Details
Theresaxx1961, lymesingerinCO, Tunnelvisionary, mmckenna, orchid_rain, Contentprof, Cornell


Follow HealingWell.com on Facebook  Follow HealingWell.com on Twitter  Follow HealingWell.com on Pinterest  Follow HealingWell.com on YouTube
Advertisement
Advertisement

©1996-2014 HealingWell.com LLC  All rights reserved.

Advertise | Privacy Policy & Disclaimer